LogicBio Therapeutics, Inc.Company Review & Valuation

LOGC
Nasdaq
Latest Price
5.52USD
Market Capitalization
127.16mUSD

About LogicBio Therapeutics, Inc.

LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effShow moreect. Its lead product candidate is LB-001 that is been developed for the treatment of Methylmalonic Acidemia, a life-threatening disease that presents at birth. LogicBio Therapeutics, Inc. was founded in 2014 and is based in Cambridge, Massachusetts.Show less

Industry
Biotechnology
HQ Location
Cambridge, Massachusetts

Stock Price

Price data not available for LogicBio Therapeutics, Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Celgene
NovaBay Pharmaceuticals
Advaxis, Inc.
Regenxbio

back to top